Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pandion Therapeutics, Inc., a biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that Don Frail,…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pandion Therapeutics, Inc., a biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that Don Frail,…
Former Novartis CEO Joseph Jimenez Joins Board of Directors, Greg Russotti, formerly of Celgene, Named CTO PHILADELPHIA–(BUSINESS WIRE)–Century Therapeutics, a…
Commencement of First-in-Human Clinical Study Within Three Years of Discovery Program Initiation Highlights the Rapid Advancement of This Orally Administered,…
PROVIDES 2020 FINANCIAL GUIDANCE Full-Year 2019 Revenues of $51.8 Billion, Reflecting 1% Operational Decline; Excluding the Impact from Consumer Healthcare(1),…
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on Chinese Pregabalin Market, 2020-2024” report has been added to ResearchAndMarkets.com’s offering. Pregabalin is a new-generation…
MACCLESFIELD, England–(BUSINESS WIRE)–Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to…
Preliminary data from The Economist Intelligence Unit Study on lung cancer policies is presented at the European Cancer Forum, after…
Clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, Adverum Biotechnologies on Tuesday announced the opening of its new corporate headquarters at one of the largest biotechnology research complexes in the San Francisco Bay Area.
BOSTON & SYDNEY–(BUSINESS WIRE)–GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2…